Home › Prostate Cancer › NCT04550845
Understanding of Genetics by Men at Risk for Prostate Cancer
RecruitingHealthy volunteers welcome
Who can join
Ages 40 to 95 · Men · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * African-American or White men * Living in a rural or urban areas * Age 40 to 95 years old * Able and willing to provide informed consent * English-speaking * Willing to participate in the study. This study will use the United States Department of Agriculture Office of Rural Development's definition of rural, which is as a city or town that has a population less than 50,000 inhabitants to define rural. This study will use the United States Census Bureau's definition of urban, which is a city or town that has a population greater than 50,000 inhabitants to define urban. Exclusion Criteria: Women will be excluded from participating in this study. However, women will be recruited to serve on an advisory panel to review the video-based educational tool for the comprehension of genomic terminology for prognostic genetic testing in patients with localized prostate cancer.
About the study
With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with make better treatment planning decisions. This study is designed to investigate the understanding of prognostic genetic technology in African American and rural White men at risk for localized prostate cancer.
What is being tested
- Focus group analyses (behavioral)
Sponsor: Mayo Clinic · Participants: 90 · Started: May 1, 2023
Contact the study team
- Ewan K Cobran, PhD · Phone: 480-301-6392
Official record on ClinicalTrials.gov — NCT04550845
Locations in the U.S.
| Arizona | Mayo Clinic, Phoenix |
| Florida | Mayo Clinic in Florida, Jacksonville |
| Minnesota | Mayo Clinic, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.